roflumilast 0.15 % Topical Cream

RxCUI
2687710
RxNorm name
roflumilast 0.15 % Topical Cream
Display name
roflumilast 0.15 % Topical Cream
Full name
roflumilast 0.15 % Topical Cream
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ZORYVEROFLUMILASTArcutis Biotherapeutics, Inc.ec1bb0d1-f38a-4080-831a-68791d1d1fdb2026-07-02Adverse reactionsExact identifier
rxcui: 2687710

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
ec1bb0d1-f38a-4080-831a-68791d1d1fdbroflumilast 0.15 % Topical CreamPSN12These highlights do not include all the information needed to use ZORYVE cream safely and effectively. See full prescribing information for ZORYVE cream. ZORYVE ® (roflumilast) cream 0.3%, 0.15%, 0.05%, for topical use Initial U.S. Approval: 201120260130
ec1bb0d1-f38a-4080-831a-68791d1d1fdbroflumilast 1.5 MG/ML Topical CreamSCD12These highlights do not include all the information needed to use ZORYVE cream safely and effectively. See full prescribing information for ZORYVE cream. ZORYVE ® (roflumilast) cream 0.3%, 0.15%, 0.05%, for topical use Initial U.S. Approval: 201120260130
ec1bb0d1-f38a-4080-831a-68791d1d1fdbroflumilast 0.15 % Topical CreamSY12These highlights do not include all the information needed to use ZORYVE cream safely and effectively. See full prescribing information for ZORYVE cream. ZORYVE ® (roflumilast) cream 0.3%, 0.15%, 0.05%, for topical use Initial U.S. Approval: 201120260130